Medicine and Dentistry
Cancer Growth
100%
Interstitial Collagenase
100%
Cancer Associated Fibroblast
100%
Tissue Inhibitor of Metalloproteinase 1
83%
Prostate Cancer
66%
Colon Carcinoma
50%
Malignant Neoplasm
33%
Neoplasm
16%
Phosphotransferase
16%
In Vitro
16%
Stroma
16%
Cancer Therapy
16%
Biological Marker
16%
Clinical Study
16%
Cancer Types
16%
Mitogen Activated Protein Kinase 3
16%
Tumor Microenvironment
16%
Cancer Tissue
16%
Fibroblast
16%
Keyphrases
Cancer Progression
100%
Matrix Metalloproteinase Inhibitors
100%
Matrix metalloproteinase-1 (MMP-1)
100%
Cancer-associated Fibroblasts
100%
Prostate Cancer
36%
In Cancer
9%
Clinical Outcomes
9%
Tumor Microenvironment
9%
Treatment Options
9%
Cancer Types
9%
Cancer Patients
9%
Novel Therapeutic Targets
9%
Kinase Activation
9%
Colon Cancer
9%
Cancer Therapy
9%
Novel Therapies
9%
ERK2
9%
Patient Plasma
9%
Functional Role
9%
In Vivo Growth
9%
Fibroblast Migration
9%
Fibroblast Proliferation
9%
Colon Tissue
9%
Pro-tumor
9%
Pro-tumor Activity
9%
Human Colon Cancer
9%
Cancer Therapeutic Target
9%
Promotive Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cancer Growth
100%
Interstitial Collagenase
100%
Tissue Inhibitor of Metalloproteinase 1
62%
Prostate Cancer
50%
Colon Carcinoma
37%
Neoplasm
12%
Phosphotransferase
12%
Biological Marker
12%
Tumor Microenvironment
12%
Clinical Study
12%
Mitogen Activated Protein Kinase 3
12%
Immunology and Microbiology
Cancer Associated Fibroblast
100%
Colon
60%
Prostate
40%
Blood Plasma
20%
Cancer Tissue
20%
Stroma
20%
Fibroblast
20%
Biochemistry, Genetics and Molecular Biology
Interstitial Collagenase
100%
Fibroblast
100%
Colon
27%
Kinase
9%
Phosphotransferase
9%
Clinical Study
9%
Blood Plasma
9%